[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100644369":3},{"organization":4,"outcomesModule":7,"designInfo":36,"detailedDescription":42,"studyPopulation":35,"armGroups":43,"interventions":55,"overallOfficials":65,"centralContacts":69,"locations":74,"responsibleParty":101,"collaborators":103,"id":111,"slug":112,"hasResults":113,"nctId":114,"briefTitle":115,"officialTitle":116,"acronym":35,"eligibilityCriteria":117,"healthyVolunteers":113,"sex":118,"minAge":119,"maxAge":35,"enrollmentInfo":120,"targetDuration":35,"studyType":123,"phases":124,"briefSummary":126,"conditions":127,"keywords":130,"overallStatus":132,"whyStopped":35,"lastUpdateSubmitDate":133,"lastUpdatePostDateStruct":134,"startDateStruct":137,"completionDateStruct":139,"leadSponsor":141,"locationsCount":142},{"fullName":5,"class":6},"Dana-Farber Cancer Institute","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":27,"otherOutcomes":35},[9,13,17,21,24],{"measure":10,"description":11,"timeFrame":12},"Prevalence of Cancer Stigma","Cancer-related stigma will be assessed using validated and adapted survey instruments among patients, caregivers, and healthcare workers. The primary outcome is the prevalence of stigma based on the adapted scale. The investigators will also assess stigma in different subgroups based on demographic, and clinical characteristics.","Baseline",{"measure":14,"description":15,"timeFrame":16},"Change in Cancer-Related Stigma Score","The outcome is defined as the change in stigma score from baseline to post-intervention among participants, with higher reductions indicating improvement in stigma.","Baseline and within 4 weeks following completion of the pilot intervention (approximately 4-5 months)",{"measure":18,"description":19,"timeFrame":20},"Rate of Acceptability of Intervention Components","Acceptability of the intervention components will be evaluated using the Acceptability of Intervention Measure (AIM). The outcome is defined as the proportion (percentage) of participants with a total AIM score ≥16 (range of scores 4 - 20), based on 4 items rated on a 5-point Likert scale (1 = completely disagree to 5 = completely agree), with higher percentages indicating greater acceptability.","Within 4 weeks following completion of the intervention delivery period (approximately Month 13)",{"measure":22,"description":23,"timeFrame":20},"Rate of Appropriateness of Intervention Components","Appropriateness of the intervention components will be evaluated using the Intervention Appropriateness Measure (IAM). The outcome is defined as the proportion (percentage) of participants with a total IAM score ≥16 (range of scores 4 - 20), based on 4 items rated on a 5-point Likert scale, with higher percentages indicating greater perceived appropriateness.",{"measure":25,"description":26,"timeFrame":20},"Rate of Feasibility of Intervention Components","Feasibility of the intervention components will be evaluated using the Feasibility of Intervention Measure (FIM). The outcome is defined as the proportion (percentage) of participants with a total FIM score ≥16 (range of scores 4 - 20), based on 4 items rated on a 5-point Likert scale, with higher percentages indicating greater feasibility.",[28,32],{"measure":29,"description":30,"timeFrame":31},"Qualitative Themes of Cancer Stigma Across Socioecological Levels- individual interviews","Cancer stigma will be qualitatively assessed from the joint qualitative analysis of individual interviews. The outcome consists of identified themes related to stigma, which will be categorized and mapped to domains of the Health Stigma and Discrimination (HSD) framework.","During the socioecological stigma assessment phase (approximately Month 2 through Month 13).",{"measure":33,"description":34,"timeFrame":31},"Qualitative Themes of Cancer Stigma Across Socioecological Levels- focus groups","Cancer stigma will be qualitatively assessed from the joint qualitative analysis of focus groups. The outcome consists of identified themes related to stigma, which will be categorized and mapped to domains of the Health Stigma and Discrimination (HSD) framework.",null,{"allocation":37,"interventionModel":38,"interventionModelDescription":35,"primaryPurpose":39,"observationalModel":35,"timePerspective":35,"maskingInfo":40},"NON_RANDOMIZED","PARALLEL","SUPPORTIVE_CARE",{"masking":41,"maskingDescription":35,"whoMasked":35},"NONE","The aim of this research study is to pilot components of an intervention to reduce the impact breast and cervical cancer stigma on patients and caregivers to improve the patient care experience and patient outcomes. The study seeks to achieve two goals. The first, to understand how stigma (negative attitudes, shame, or discrimination) related to breast and cervical cancer shows up in Rwanda-for patients, within families and caregiving relationships, and across the healthcare system. To do this, the team will use a combination of surveys and in-depth conversations to capture both numbers and lived experiences.\n\nThe second study aim is to co-develop culturally appropriate, community-informed interventions that translate research findings into practical supportive care strategies for cancer patients and caregivers. A Community Advisory Board comprising survivors, caregivers, community health workers, nurses, social workers, mental health professionals, and an oncologist will guide intervention development and implementation. Using a community-based participatory approach and intervention mapping, the team will design the RISE program, which includes: (1) resilience skills training for patients delivered in four group sessions aligned with chemotherapy cycles; (2) peer support groups for caregivers addressing caregiving burden, emotional well-being, stigma, communication, and community resources; and (3) survivor-informed videos presenting lived experiences and coping strategies.\n\nApproximately 1,086 participants will be enrolled.",[44,50],{"label":45,"type":46,"description":47,"interventionNames":48},"Patient and Caregiver Intervention (RISE)","EXPERIMENTAL","Patients with breast cancer and their caregivers will receive the RISE intervention, which includes resilience skills building (patients), peer-to-peer support groups (caregivers), and exposure to survivors through video storytelling (both).",[49],"Behavioral: Behavioral: RISE Intervention",{"label":51,"type":46,"description":52,"interventionNames":53},"Community Health Worker (CHW) Intervention","Community health workers will receive exposure to survivors' components and an educational curriculum delivered via presentation, booklet, and video.",[54],"Behavioral: Behavioral: CHW Educational Intervention",[56,61],{"type":57,"name":58,"description":59,"armGroupLabels":60,"otherNames":35},"BEHAVIORAL","Behavioral: RISE Intervention","Components: Resilience skills building (psychoeducation), peer-to-peer support groups, exposure to survivors via video storytelling Target: Patients with breast cancer and their caregivers",[45],{"type":57,"name":62,"description":63,"armGroupLabels":64,"otherNames":35},"Behavioral: CHW Educational Intervention","Components: Exposure to survivors (video storytelling), educational curriculum (presentation, booklet, video) Target: Community health workers",[51],[66],{"name":67,"affiliation":5,"role":68},"Temidayo Fadelu, MD","PRINCIPAL_INVESTIGATOR",[70],{"name":67,"role":71,"phone":72,"phoneExt":35,"email":73},"CONTACT","+1 617-632-3779","temidayo_fadelu@dfci.harvard.edu",[75,92],{"facility":76,"status":35,"city":77,"state":35,"zip":35,"country":78,"countryCode":79,"cosmosGeoPoint":80,"geoPoint":85,"contacts":86},"Butaro Level 2 Teaching Hospital (BL2TH), Ministry of Health","Butaro","Rwanda","RW",{"type":81,"coordinates":82},"Point",[83,84],29.8313,-1.4079,{"lat":84,"lon":83},[87,91],{"name":88,"role":71,"phone":89,"phoneExt":35,"email":90},"Eulade Rugengamanzi, MD","+250 783 849 767","erugengamanzi@ughe.org",{"name":88,"role":68,"phone":35,"phoneExt":35,"email":35},{"facility":93,"status":35,"city":77,"state":35,"zip":35,"country":78,"countryCode":79,"cosmosGeoPoint":94,"geoPoint":96,"contacts":97},"University of Global Health Equity (UGHE)",{"type":81,"coordinates":95},[83,84],{"lat":84,"lon":83},[98,100],{"name":99,"role":71,"phone":89,"phoneExt":35,"email":90},"Eulade Rugengamazi, MD",{"name":99,"role":68,"phone":35,"phoneExt":35,"email":35},{"type":68,"investigatorFullName":67,"investigatorTitle":102,"investigatorAffiliation":5,"oldNameTitle":35,"oldOrganization":35},"Principal Investigator",[104,107,109],{"name":105,"class":106},"Dana-Farber\u002FHarvard Cancer Center (DF\u002FHCC) Boston, MA","UNKNOWN",{"name":108,"class":6},"American Association for Cancer Research",{"name":110,"class":6},"Breast Cancer Research Foundation","100644369","breast-and-cervical-cancer-stigma-in-rwanda-100644369",false,"NCT07663006","Breast and Cervical Cancer Stigma in Rwanda","Assessing Breast and Cervical Cancer Stigma and Piloting a Mitigating Intervention in Rwanda","Aim 1 Inclusion and Exclusion Criteria Aim 1 Interviews and Surveys\n\nIndividual interviews and surveys:\n\nPotential patients will be identified by the clinical team from physical and electronic registries of patients. Potential participants will be screened for eligibility by the study research assistant.\n\nInclusion Criteria\n\n* Patients with pathologically confirmed breast or cervical cancer\n* Patients receiving treatment at BCCOE during the study period\n* Age 18 and over\n* Ability to provide informed consent\n* Ability to participate in interview or surveys in English or Kinyarwanda\n\nExclusion Criteria\n\n* Unwilling or Unable to consent to participation.\n* Unable to comprehend study language (Kinyarwanda or English)\n* Individuals who are not yet adults (infants, children, teenagers)\n* Prisoners\n* Pregnant women Note: Determination of ability to consent will be made by trained study staff prior to enrollment\n\nInterpersonal interviews and surveys:\n\nCaregivers of the potential patients will be identified from the potential patients. Potential patients will be identified by the clinical team from physical and electronic registries of patients. Potential participants will be screened for eligibility by the study research assistant.\n\nInclusion Criteria\n\n* Caregiver (including spouses, children, family members or other individuals as designated by patients) of patients with pathologically confirmed breast or cervical cancer who are actively receiving treatment at BCCOE during the study period\n* Age 18 and over\n* Ability to provide informed consent\n* Ability to participate in interview or surveys in English or Kinyarwanda\n\nExclusion Criteria\n\n* Unwilling or Unable to consent to participation.\n* Unable to comprehend study language (Kinyarwanda or English)\n* Individuals who are not yet adults (infants, children, teenagers)\n* Prisoners\n* Pregnant women Note: Determination of ability to consent will be made by trained study staff prior to enrollment\n\nInstitutional Focus group:\n\nAn official participation letter will be sent from BL2TH to leaders of the preselected facilities. Interested participants will be encouraged to contact the study team. Potential participants will be invited by their hospital\u002Fcenter leadership and screened for eligibility by the study research assistant.\n\nInclusion Criteria\n\n* Healthcare Worker\n* Working in a preselected health center, district hospital, provincial hospital in the Northern Province\n* Age 18 or older\n* Ability to provide informed consent\n* Ability to participate in interview or surveys in English or Kinyarwanda\n\nExclusion Criteria\n\n* Unwilling or Unable to consent to participation.\n* Unable to comprehend study language (Kinyarwanda or English)\n* Individuals who are not yet adults (infants, children, teenagers)\n* Prisoners\n* Pregnant women Note: Determination of ability to consent will be made by trained study staff prior to enrollment\n\nInstitutional surveys:\n\nFormal participation invitation will be sent to the Rwanda Medical and Dental Council, National Council of Nurses and Midwives, and the Rwanda Allied Health Professions Council. Potential participants will be screened for eligibility electronically and informed consent obtained electronically.\n\nInclusion Criteria\n\n* Healthcare Worker\n* Registered with relevant professional organization in Rwanda\n* Age 18 or older\n* Ability to provide informed consent\n* Ability to participate in surveys in English or Kinyarwanda\n\nExclusion Criteria\n\n* Unwilling or Unable to consent to participation.\n* Unable to comprehend study language (Kinyarwanda or English)\n* Individuals who are not yet adults (infants, children, teenagers)\n* Prisoners\n* Pregnant women Note: Determination of ability to consent will be made by trained study staff prior to enrollment\n\nAim 2 Inclusion and Exclusion Criteria Aim 2 Intervention pilot (patient, caregivers and community health workers)\n\nPatient and Caregiver Pilot:\n\nInclusion Criteria\n\n* Patients with pathologically confirmed breast cancer who are actively receiving curative-intent treatment at BCCOE during the study period and a designated caregiver\n* Patients getting systemic neoadjuvant chemotherapy who are expected in the clinic on a 3-week cycle\n* Patients who have at least 4 cycles of therapy remaining\n* Age 18 and over\n* Ability to provide informed consent\n* Ability to participate in pilot, interview, and surveys in English or Kinyarwanda\n\nExclusion Criteria\n\n* Unwilling or Unable to consent to participation.\n* Unable to comprehend study language (Kinyarwanda or English)\n* Individuals who are not yet adults (infants, children, teenagers)\n* Prisoners\n* Pregnant women Note: Determination of ability to consent will be made by trained study staff prior to enrollment\n\nCommunity Health Worker Pilot:\n\nInclusion Criteria\n\n* Community Health Worker registered with relevant healthcare facilities in Northern Rwanda\n* Age 18 or older\n* Willing to engage in activities related to breast and cervical cancer and to support survivors\n* Ability to provide informed consent\n* Ability to participate in pilot, interview, and surveys in English or Kinyarwanda\n\nExclusion Criteria\n\n* Unwilling or Unable to consent to participation\n* Unable to comprehend study language (Kinyarwanda or English)\n* Individuals who are not yet adults (infants, children, teenagers)\n* Prisoners\n* Pregnant women","FEMALE","18 Years",{"count":121,"type":122},1116,"ESTIMATED","INTERVENTIONAL",[125],"NA","This study aims to assess breast and cervical cancer stigma and pilot a multi-modal intervention to mitigate stigma among patients, caregivers, and community health workers in Rwanda. The elements include resilience training (patient), support group (caregivers), or exposure to survivors by video and in-person (patient, caregivers, and community health workers), and educational curriculum (community health workers).",[128,129],"Breast Cancer","Cervical Cancer",[128,129,131],"Cancer Stigma","NOT_YET_RECRUITING","2026-06-22",{"date":135,"type":136},"2026-06-23","ACTUAL",{"date":138,"type":122},"2026-11-01",{"date":140,"type":122},"2029-12-01",{"name":5,"class":6},2]